National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
72.03
-0.53 (-0.73%)
Aug 28, 2026, 4:00 PM EDT - Market closed

National Health Investors Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,5373,6383,1482,4242,2662,635
Market Cap Growth
-4.16%15.58%29.83%7.00%-14.01%-14.83%
Enterprise Value
4,7854,6834,2873,5733,3723,884
Last Close Price
72.0374.6264.5049.3543.0744.52

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Price/FFO Ratio
16.1016.0514.1811.2412.139.64
Price/AFFO Ratio
-16.0614.1811.2512.149.65
PE Ratio
20.7925.6322.8317.8834.1223.57
PS Ratio
8.129.599.387.578.138.87
PB Ratio
2.252.362.271.901.761.74
P/OCF Ratio
14.2215.3815.1513.1412.2312.50

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
10.9812.3512.7811.1512.1013.07
EV/EBITDA Ratio
16.5216.9216.4714.3515.7114.63
EV/EBIT Ratio
24.1023.9222.7019.9623.4621.04

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.800.760.830.890.890.82
Debt / EBITDA Ratio
4.414.214.414.565.354.68
Net Debt / Equity Ratio
0.790.740.810.880.880.80
Net Debt / EBITDA Ratio
4.314.144.324.475.264.54
Asset Turnover
0.150.140.130.130.100.10
Quick Ratio
1.200.501.531.531.562.12
Current Ratio
1.820.541.641.712.353.28
Return on Equity (ROE)
10.72%9.63%10.28%10.48%4.67%7.37%
Return on Assets (ROA)
4.38%4.52%4.63%4.48%3.36%3.87%
Return on Invested Capital (ROIC)
6.97%7.48%7.64%7.39%5.53%6.38%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
4.71%3.91%4.38%5.59%2.93%4.24%
Dividend Yield
5.22%4.88%5.58%7.29%8.36%8.54%
Payout Ratio
108.53%119.36%113.42%115.17%243.62%163.59%
Buyback Yield / Dilution
-5.73%-6.69%-1.64%3.14%2.04%-2.31%
Total Shareholder Return
-0.51%-1.81%3.94%10.43%10.40%6.23%
SEC Filings: 10-K · 10-Q